about
Immune checkpoint and inflammation as therapeutic targets in pancreatic carcinomaMonitoring of the Immune Dysfunction in Cancer PatientsImmunotherapy of Malignant Tumors in the Brain: How Different from Other Sites?Cancer immunotherapy: how low-level ionizing radiation can play a key role.Epigenetic Strategies to Boost Cancer Immunotherapies.Unraveling the role of preexisting immunity in prostate cancer patients vaccinated with a HER-2/neu hybrid peptide.Predictive biomarkers for the efficacy of peptide vaccine treatment: based on the results of a phase II study on advanced pancreatic cancer.A retrospective analysis comparing APCEDEN(®) dendritic cell immunotherapy with best supportive care in refractory cancer.Influence of opioids on immune function in patients with cancer pain: from bench to bedside.Resistance to anticancer immunity in cancer patients: potential strategies to reverse resistance.Markers and function of human NK cells in normal and pathological conditions.Co-inhibitory blockade while preserving tolerance: checkpoint inhibitors for glioblastoma.FOCIS goes south: advances in translational and clinical immunology.The role and significance of VEGFR2+ regulatory T cells in tumor immunityPhase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection.Interleukin-6/STAT3 signaling as a promising target to improve the efficacy of cancer immunotherapy.Introduction: Cancer Immunology Special Issue-Immunopathology.Effects of preemptive analgesia with flurbiprofen ester on lymphocytes and natural killer cells in patients undergoing esophagectomy: A randomized controlled pilot study.Immunotherapy and gene therapy as novel treatments for cancer.A pilot study comparing T-regulatory cell function among healthy children in different areas of Gansu, China.Requirement of Treg-intrinsic CTLA4/PKCη signaling pathway for suppressing tumor immunity.Unconventional Pro-inflammatory CD4+ T Cell Response in B Cell-Deficient Mice Infected with Trypanosoma cruzi.Family A and B DNA Polymerases in Cancer: Opportunities for Therapeutic Interventions.Th17, synchronically increased with Treg and Breg, promoted by tumor cells via cell-contact in primary hepatic carcinoma.The Dark Side of IFN-γ: Its Role in Promoting Cancer Immunoevasion.Regulatory T Cells: Molecular and Cellular Basis for Immunoregulation.Epithelial-mesenchymal transition (EMT) signature is inversely associated with T-cell infiltration in non-small cell lung cancer (NSCLC).Contribution of Regulatory T Cells in Nucleotide-Binding Oligomerization Domain 2 Response to Influenza Virus Infection.Regulatory T Cells and Their Prognostic Relevance in Hematologic Malignancies.Regulatory T cells in retroviral infections.Tumor-derived high-mobility group box 1 and thymic stromal lymphopoietin are involved in modulating dendritic cells to activate T regulatory cells in a mouse model.Vitamin C Fosters the In Vivo Differentiation of Peripheral CD4+ Foxp3- T Cells into CD4+ Foxp3+ Regulatory T Cells but Impairs Their Ability to Prolong Skin Allograft Survival.CD45RA-Foxp3high regulatory T cells have a negative impact on the clinical outcome of head and neck squamous cell carcinoma.Monoclonal antibodies against cutaneous T-cell lymphomas.TSC2-deficient tumors have evidence of T cell exhaustion and respond to anti-PD-1/anti-CTLA-4 immunotherapy.Current Strategies to Enhance Anti-Tumour Immunity.IL23 and TGF-ß diminish macrophage associated metastasis in pancreatic carcinoma.Combination of sorafenib and cytokine-induced killer cells in metastatic renal cell carcinoma: a potential regimen.Putative Biomarkers of Response to Treatment in Breast Cancer Patients: A Pilot Assay.Development of a vaccine based on bacteria-mimicking tumor cells coated with novel engineered toll-like receptor 2 ligands.
P2860
Q28069864-05AA6721-221B-4A8C-82B1-6BA0769FBA34Q28072712-4753C900-40DB-4A76-9773-CFC6423835AFQ28078539-EAFF6156-EDB9-4170-92E8-93B9FBBA75B7Q30235014-AFCEFE14-1559-40FB-BC93-725D23F508C3Q33838340-85C5F8E2-4FAF-4694-9F1C-958C5711A5CDQ37414561-D8980E30-688B-4A4B-A639-E13F913E083BQ37671162-DE87450D-1578-473D-8F66-AD2802F33EB6Q38609735-7A498BBE-7F95-4738-9F01-FEDC65BAA11DQ38736927-336504CF-1FE7-4296-907B-D1B64E2F4AF9Q39013616-C47D004A-6A47-47AA-A56A-9E75D3CBC8E5Q39068084-D953AE36-0F0E-42AC-921B-2EB5979EE584Q39160992-E0B6CDB9-C6A8-4BF7-A1C3-6CBCB47630A7Q40064195-42C2ED06-C4DE-43A2-8396-A1397EC5FED1Q41499942-DAD733FA-D1D4-43A1-9BAE-4E5D12C3CC38Q41706961-4B827F40-1B23-4DB4-AB3C-2089278DA9F9Q42288627-2893CE54-C845-4BCA-BCE9-44438A4D4B7CQ42354401-D138EDEC-D84D-4BB8-8C01-FBD000A8822FQ43260533-1035A54F-6D42-47F7-A5B4-F432E35CA4D0Q45875535-D49CA830-165B-4DE2-AB2B-0A9AF40067E5Q46268215-CB134139-8210-433E-8201-BCB826415C35Q46909626-87B43787-62A2-4FF8-B2D7-2F5F2241108EQ47162312-8C1F5B58-4504-48A3-9A52-5A32AAE859FFQ47209159-BD709894-6967-40FD-A9A7-7D0044FF6E54Q47218277-8981FB5A-F8FE-45C6-A898-172B44625267Q48337458-F8A1C4AF-0B09-4D37-BBFC-1855EECE35BEQ48668293-4A2C93A1-AA54-4726-AB62-A3C4FEFA8305Q49243761-960C4BAB-D3B3-4982-853F-95131CC6EA03Q49612388-9672A32D-5D83-4E0E-82B2-D4ADB1753C65Q49704420-6F968EB6-CC21-4E09-B6FA-6A305AD00793Q49979151-950CA7E1-EBEB-41AF-8A9E-8A7CC0F61A5AQ50109080-D9368731-4A1F-4EF9-B878-FD66505190FFQ50321579-7EC91DAF-6285-4C2F-992F-05C1E40AABABQ50975027-455DFAB7-8775-49BB-9325-B3F188FEE18CQ51803389-5B0E8E24-F367-40D3-8751-159636FF5A65Q52316792-13DE1389-A0B6-43A7-868A-FBBE10446031Q52344613-2BC49AF1-2785-467E-A7E5-646B693601BEQ52719969-5B01F8A5-750B-451C-9C0C-3ED32016EE48Q52856745-F489F3D2-AB23-401E-95BF-A0CFFFA2867CQ52878728-0849FB1E-AD61-4B41-805E-8D2D7E112535Q54943714-C480244E-F5DA-4CA8-AE12-D80216AD9273
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Roles of regulatory T cells in cancer immunity.
@en
type
label
Roles of regulatory T cells in cancer immunity.
@en
prefLabel
Roles of regulatory T cells in cancer immunity.
@en
P2860
P356
P1476
Roles of regulatory T cells in cancer immunity.
@en
P2093
Hiroyoshi Nishikawa
Yoshiko Takeuchi
P2860
P304
P356
10.1093/INTIMM/DXW025
P577
2016-05-09T00:00:00Z